Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope.
Manthan KathrotiyaRadhakrishnan VsSaurabh J BhaveJeevan KumarMita RoychowdhuryIndu ArunJayanta DasMammen ChandyReena NairPublished in: Clinical case reports (2020)
This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV-negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.
Keyphrases
- multiple myeloma
- antiretroviral therapy
- diffuse large b cell lymphoma
- stem cell transplantation
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- acute lymphoblastic leukemia
- acute myeloid leukemia
- hepatitis c virus
- bone marrow
- case report
- hiv aids
- men who have sex with men
- hodgkin lymphoma
- newly diagnosed
- peripheral blood
- low dose